RUNX1 and acute lymphoblastic leukemia: In common ALL patients who expressed TEL/AML1+, the 11 new subpopulations were present at a high frequency in the CD34−CD10+CD19+CD179a+ and CD34−CD10−CD19+ populations, which were higher than those in the other patients.